Cognition Therapeutics (CGTX) Assets (2020 - 2026)
Cognition Therapeutics (CGTX) posted quarterly Assets of $36.1 million for Q1 2026, up 53.79% year-over-year from $23.5 million in Q1 2025, and down 25.32% quarter-over-quarter from $48.4 million in Q4 2025.
Cognition Therapeutics (CGTX) Assets (2020 - 2026) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Assets for 7 consecutive years, with $36.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 53.79% year-over-year to $36.1 million; the TTM figure through Mar 2026 stood at $36.1 million (up 53.79% YoY), while the FY2025 annual figure was $48.4 million, up 60.05% from the prior year.
- Assets slipped to $36.1 million in Q1 2026 per CGTX's latest filing, from $48.4 million in the prior quarter.
- Across five years, Assets topped out at $58.7 million in Q1 2022 and bottomed at $19.6 million in Q2 2025.
- Historically, Assets has averaged $40.1 million across 5 years, with a median of $38.9 million in 2024.
- Annual changes were most pronounced in 2022 — Assets surged 300.01% — and 2025, when it plunged 42.91%.
- Cognition Therapeutics' Assets stood at $50.4 million in 2022, then slumped by 30.27% to $35.2 million in 2023, then retreated by 14.02% to $30.2 million in 2024, then jumped by 60.05% to $48.4 million in 2025, then retreated by 25.32% to $36.1 million in 2026.
- Business Quant data shows CGTX's Assets at $36.1 million in Q1 2026, $48.4 million in Q4 2025, and $43.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | 38.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.90 Mn |
| Mar 31, 2026 | 36.14 Mn |
| Dec 31, 2025 | 48.39 Mn |
| Sep 30, 2025 | 43.40 Mn |
| Jun 30, 2025 | 19.62 Mn |
| Mar 31, 2025 | 23.50 Mn |
| Dec 31, 2024 | 30.23 Mn |
| Sep 30, 2024 | 27.58 Mn |
| Jun 30, 2024 | 34.37 Mn |
| Mar 31, 2024 | 38.85 Mn |
| Dec 31, 2023 | 35.16 Mn |
| Sep 30, 2023 | 38.77 Mn |
| Jun 30, 2023 | 43.96 Mn |
| Mar 31, 2023 | 45.66 Mn |
| Dec 31, 2022 | 50.43 Mn |
| Sep 30, 2022 | 53.56 Mn |
| Jun 30, 2022 | 52.81 Mn |
| Mar 31, 2022 | 58.70 Mn |
| Dec 31, 2021 | 59.14 Mn |
| Sep 30, 2021 | 13.39 Mn |